BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11986603)

  • 1. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression in markers for thrombin, platelet activation, and inflammation in cell saver versus systemic blood in patients undergoing on-pump coronary artery bypass graft surgery.
    Takayama H; Soltow LO; Aldea GS
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):519-23. PubMed ID: 17678777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
    ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery.
    Nakahira A; Sasaki Y; Hirai H; Matsuo M; Morisaki A; Suehiro S; Shibata T
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1289-97. PubMed ID: 20800241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function.
    Butler J; Murithi EW; Pathi VL; MacArthur KJ; Berg GA
    Ann Thorac Surg; 2002 Jul; 74(1):139-42. PubMed ID: 12118746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations.
    McCarthy PM; Yared JP; Foster RC; Ogella DA; Borsh JA; Cosgrove DM
    Ann Thorac Surg; 1999 May; 67(5):1268-73. PubMed ID: 10355394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
    Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
    J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-bonded circuits without a cardiotomy: a description of a minimally invasive technique of cardiopulmonary bypass.
    Lilly KJ; O'Gara PJ; Treanor PR; Crowley R; Reardon DL; Shapira OM; Khuri SF; Aldea GS; Shemin RJ
    Perfusion; 2002 Mar; 17(2):95-7. PubMed ID: 11958310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.
    Weerwind PW; Maessen JG; van Tits LJ; Stad RK; Fransen EJ; de Jong DS; Penn OC
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1633-41. PubMed ID: 8523873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.